NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . July 6th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

American Association for Cancer Research - Green tea may affect prostate cancer progression

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College - NEJM study points to new era in hepatitis C treatment

ImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Signs Manufacturing Agreement with Formatech for Clinical Trial of ICT-121 Immunotherapy

Influenza - Preclinical Proof-of-Concept Studies Published for Novavax Seasonal Influenza Virus-Like-Particle Vaccine

Neovacs - Neovacs to Expand Clinical Testing of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings from a Phase I/II Study

Acne Vulgaris - Studies from Columbia University in the area of acne vulgaris described

Angiogenesis - Data from University of Connecticut advance knowledge in angiogenesis

Angiotensins - Studies from Technical University in the area of angiotensins described

Antisense Technology - Reports from University of Pittsburgh add new data to research in antisense technology

Breast Cancer - Investigators at University of California have published new data on breast cancer

Cancer - Data from C.I. Ripamonti et al provide new insights into cancer

Cancer - Scientists at Pfizer Inc. publish research in cancer

Cancer - Studies from University of Paris describe new findings in cancer

Glioblastoma - Reports from T. Lesimple et al highlight recent research in glioblastoma

Glioblastoma - Reports on glioblastoma findings from M.J. Vandenbent and co-researchers provide new insights

Glioma - Research conducted at Duke University has updated our knowledge about glioma

HIV/AIDS - New HIV/AIDS data have been reported by researchers at Harvard University

HIV/AIDS Cancer - Research from University of Louvain has provided new information about HIV/AIDS cancer

Hypertrophy - Research from B.L. Thurberg and colleagues provide new insights into hypertrophy

Interferon - Research in the area of interferon reported from B. Escudier and colleagues

Life Sciences - New life sciences study findings have been reported from National Institute of Neurological Disorders and Stroke

Lupus - Study results from C. Penarossi and colleagues in the area of lupus published

Non-Hodgkin Lymphoma - Study results from University of Wisconsin update understanding of non-hodgkin lymphoma

Non-Small Cell Lung Cancer - New non-small cell lung cancer data have been reported by A. Inoue and co-authors

Non-Small Cell Lung Cancer - New non-small cell lung cancer study findings have been reported from D.D. Karp et al

Non-Small Cell Lung Cancer - Reports by R.B. Natale and co-researchers describe recent advances in non-small cell lung cancer

Non-Small Cell Lung Cancer - Research on non-small cell lung cancer described by scientists at Ottawa Hospital

Non-Small Cell Lung Cancer - Studies from A.B. Sandler and co-researchers update current data on non-small cell lung cancer

Pancreatic Cancer - New pancreatic cancer data have been reported by researchers at University Hospital

Pancreatic Cancer - Research in the area of pancreatic cancer reported from University of Texas

Pharmacokinetics - New findings from D.E. Vaughn and co-researchers in the area of pharmacokinetics described

Prostate Cancer - Research from University of Paris has provided new data on prostate cancer

Radiation Therapy - Researchers at University of Colorado publish new data on radiation therapy

Radiation Therapy - Scientists at University of Colorado publish new data on radiation therapy

Small Cell Lung Cancer - New small cell lung cancer study findings have been reported from University of California

Soft Tissue Sarcoma - Study data from University of Barcelona update knowledge of soft tissue sarcoma

Therapy - Data from J.S. Mccune et al provide new insights into therapy

Thrombocytopenia - Study results from University of Manchester provide new insights into thrombocytopenia

Vascular Endothelial Growth Factor - Studies from R.T. Kloos et al have provided new data on vascular endothelial growth factor

Vascular Endothelial Growth Factor - Studies from University of Texas provide new data on vascular endothelial growth factor

Brachytherapy - Study findings on brachytherapy are outlined in reports from University Hospital, Department of Radiation Oncology

Breast Cancer - Researchers from National Cancer Institute discuss findings in breast cancer

Cancer Gene Therapy - Data on cancer gene therapy detailed by C.N. Sternberg and co-authors

Cancer Therapy - Data on cancer therapy discussed by researchers at Fox Chase Cancer Center, Department of Medical Oncology

Head and Neck Cancer Therapy - Royal Marsden Hospital reports research in head and neck cancer therapy

Prostate Cancer Risk Factors - Study results from University of Vienna in the area of prostate cancer risk factors published

Prostate Cancer Therapy - Research on prostate cancer therapy published by scientists at National Cancer Institute

Rectal Cancer Therapy - Researchers from University of Frankfurt publish findings in rectal cancer therapy

Acucela - Acucela’s Novel Visual Cycle Modulator Demonstrates Promise as a Treatment for Dry Age-Related Macular Degeneration

Advaxis, Inc. - Advaxis Completes Debt Financing

Advaxis, Incorporated - Advaxis Engages the Numoda Corporation to Oversee Phase II Clinical Trials of ADXS11-001

Antigenics Inc. - Antigenics Announces Expansion of Investigator-Sponsored Study for Glioma

Atox Bio Ltd. - Atox Bio and Fast-Track Drugs & Biologics Sign an R&D Collaboration Agreement for the Development of Therapeutics for Sepsis and Septic Shock

Biovail Corporation - Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine

Bladder Cancer - Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen

Cancer - Biomodels' Oral Mucositis Expertise Speeds FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients

Cancer Vaccines - Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer

Cerulean Pharma Inc. - Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation

Cougar Biotechnology, Inc. - Cougar Biotechnology Announces Dismissal of Class Action Complaint Seeking to Enjoin Tender Offer and Termination of Hart-Scott-Rodino Waiting Period

Cystic Fibrosis - Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM)

Diabetes - Living Cell Technologies' Diabetes Clinical Trial Authorized by New Zealand Government

Diabetes - Spherix Announces Full-Scale Production of Pharmaceutical Tagatose

Diabetes - Spherix Announces Positive Phase 2 Study Results

Enzon Pharmaceuticals, Inc. - Enzon Commences Phase II Trial of PEG-SN38

Fabry Disease - Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease

Hepatitis C Virus - Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis

HIV/AIDS - GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

Inotek Pharmaceuticals - Inotek Pharmaceuticals’ Novel Glaucoma Candidate, INO-8875, Significantly Reduces Intraocular Pressure in Phase 1/2 Study

Intrexon Corporation - Intrexon Corporation Secures Additional $10 Million of Series C-2 Investment

Ligand Pharmaceuticals Incorporated - Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix

Lung Cancer - Ym Biosciences Reports Daiichi-sankyo Enrolls First Patients In Phase Ii, First-line Lung Cancer Trial With Nimotuzumab

MannKind Corporation - MannKind Closes Acquisition of Insulin Assets from Pfizer

Muscular Dystrophy - Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy

Myelofibrosis - Cytopia Lodges IND for JAK2 Inhibitor CYT387

Osiris Therapeutics, Inc. - Osiris Therapeutics Reports Interim Data for COPD Stem Cell Study

Pfizer Inc - Sutent Significantly Improved Progression-Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors

Pharmaceuticals - Aegerion Pharmaceuticals Announces Final Lomitapide (AEGR-733) Phase II Data

Pharmaceuticals - China Pharma Holdings, Inc. Announces SFDA Approval for Rosuvastatin Clinical Trials

Pierre Fabre Sa - Positive CHMP Opinion for JAVLOR in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen

Prostate Cancer - OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer



Return to Top of Page

-----------------------
PR Login